Estudio de zilovertamab vedotin como monoterapia y en combinación con nemtabrutinib en participantes con neoplasias malignas de células B agresivas e indolentes
The purpose of this study is to assess the safety and tolerability of zilovertamab vedotin as monotherapy and in combination in participants with select B-cell lymphomas including mantle cell lymphoma (MCL),